DeutschNewstral
Article
jdsupra.com on 2016-09-16 21:57
Amgen v. Hospira: Amgen Files Appeal Brief at Federal Circuit
Related news
- Hospira Files Responsive Appeal Brief in Amgen v. Hospira Litigationjdsupra.com
- Sandoz Files Responsive Brief in Amgen v. Sandoz Appealjdsupra.com
- Amgen v. Hospira: Federal Circuit Oral Argument Heldjdsupra.com
- Amgen v. Sandoz Update -- BIO Files an Amicus Brief at the Federal Circuitjdsupra.com
- Amgen v. Hospira: Hospira Files a Motion for Summary Judgment of Non-Infringementjdsupra.com
- Update: Amgen v. Hospirajdsupra.com
- Amgen Files Reply Brief in Sandoz v. Amgenjdsupra.com
- Federal Circuit affirms Safe Harbor ruling and $70 million award in Amgen Inc. v. Hospira, Inc.jdsupra.com
- Federal Circuit Clarifies Limits of Safe Harbor Defense in Amgen v. Hospirajdsupra.com
- Amgen v. Hospira: Amgen’s Appeal to the Fed. Cir. Will Proceed on the Meritsjdsupra.com
- Amgen v. Hospira: Amgen Appeals Discovery Rulingjdsupra.com
- Biosimilars Council Files Amicus Brief in Sandoz v. Amgenjdsupra.com
- List it or Lose it: The Federal Circuit Weighs in on the Amgen v. Hospira Discovery Disputejdsupra.com
- Amgen v. Sandoz: Federal Circuit Grants Injunction Pending Appealjdsupra.com
- Hospira Opposes Amgen’s PI Motion in Amgen v. Hospirajdsupra.com
- Amgen Files Cross-Appeal In Epoetin Alfa Biosimilar Casejdsupra.com
- Coherus Files Responsive Appellate Brief in Amgen v. Coherus (pegfilgrastim)jdsupra.com
- Biosimilars Council Files Amicus Brief in support of Apotex’s Petition for Certiorari in Amgen v. Apotexjdsupra.com
- Solicitor General Files Brief Recommending Supreme Court Hear Sandoz v. Amgenjdsupra.com
- Amgen v. Sanofi Praulent® Litigation Once Again on Appeal before the Federal Circuitjdsupra.com